• Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

UCB:BB

60.8600 EUR 1.1900 1.99%

As of 05:48:26 ET on 04/24/2014.

Snapshot for UCB SA (UCB)

Open: 59.6500 Day's Range: 58.9100 - 61.2500 Volume: 149,780
Previous Close: 59.6700 52wk Range: 38.0100 - 61.2500 1-Yr Rtn: +31.05%

Stock Chart for UCB

No chart data available.
  • UCB:BB 60.7400
  • 1D
  • 1M
  • 1Y
59.6700
Interactive UCB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UCB

Current P/E Ratio (ttm) 54.3393
Estimated P/E(12/2014) 30.0099
Relative P/E vs. BEL20 1.3649
Earnings Per Share (EUR) (ttm) 1.1200
Est. EPS (EUR) (12/2014) 2.0280
Est. PEG Ratio 2.1023
Market Cap (M EUR) 11,837.61
Shares Outstanding (M) 194.51
30 Day Average Volume 246,053
Price/Book (mrq) 2.3662
Price/Sale (ttm) 3.6269
Dividend Indicated Gross Yield 1.71%
Cash Dividend (EUR) 0.7800
Dividend Ex-Date 04/29/2014
5 Year Dividend Growth 2.09%
Next Earnings Announcement 07/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UCB

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for UCB

UCB SA is a biopharmaceutical company. The Company specializes in the treatment of central nervous system disorders, inflammatory diseases, and oncology. UCB operates worldwide.

Roch F DoliveuxChief Executive OfficerJean-Christophe TellierExec VP:Biopharma/CEO-Elect
Detlef ThielgenExec VP/CFOIsmail KolaExec VP/Pres:Newmedicines
More Company Profile & Key Executives for UCB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil